Table 1 Basal characteristics of participants across VAI quintiles, among men
Q1 | Q2 | Q3 | Q4 | Q5 | ||
|---|---|---|---|---|---|---|
N = 658 | N = 563 | N = 614 | N = 475 | N = 464 | P for trend | |
VAI range | 0.27-1.49 | 1.49-2.26 | 2.26-3.24 | 3.24-4.88 | 4.89-29.84 | |
Age (years) | 41.43 (10.86) | 45.18 (11.36) | 47.70 (11.80) | 48.30 (11.64) | 49.79 (11.11) | 0.010 |
Life style modification | 263 (0.4) | 220 (0.39) | 221 (0.36) | 185 (0.39) | 190 (0.41) | 0.764 |
Smoking | 184 (0.28) | 157 (0.28) | 177 (0.29) | 132 (0.28) | 144 (0.31) | 0.451 |
Diabetes | 32 (0.05) | 44 (0.08) | 66 (0.11) | 89 (0.19) | 100 (0.22) | < 0.001 |
Anti-hypertensive drug | 46 (0.07) | 39 (0.07) | 43 (0.07) | 38 (0.08) | 32 (0.07) | 0.720 |
SBP (mm Hg) | 113.73 (16.81) | 119.67 (18.71) | 123.54 (20.84) | 126.18 (21.21) | 129.35 (21.43) | < 0.001 |
DBP (mm Hg) | 74.98 (9.81) | 78.03 (10.26) | 80.16 (10.90) | 81.35 (10.73) | 82.83 (10.62) | < 0.001 |
Weight (kg) | 64.06 (10.95) | 67.41 (12.08) | 69.62 (11.33) | 71.27 (12.43) | 72.12 (11.18) | < 0.001 |
Waist (cm) | 82.01 (10.83) | 87.93 (11.67) | 91.12 (10.95) | 93.68 (11.31) | 96.31 (10.17) | < 0.001 |
Height (cm) | 156.46 (5.78) | 156.13 (6.11) | 155.25 (5.69) | 155.54 (5.92) | 155.27 (5.76) | < 0.001 |
Hip circumference (cm) | 102.24 (8.78) | 104.40 (9.34) | 106.00 (9.59) | 106.77 (9.50) | 106.82 (9.14) | < 0.001 |
BMI (kg.m-2) | 26.20 (4.50) | 27.66 (4.73) | 28.90 (4.58) | 29.42 (4.63) | 29.90 (4.25) | < 0.001 |
WHpR | 80.16 (7.37) | 84.20 (7.97) | 86.01 (7.52) | 87.77 (7.74) | 90.30 (7.50) | < 0.001 |
WHtR | 52.51 (7.40) | 56.42 (7.93) | 58.77 (7.43) | 60.29 (7.43) | 62.10 (6.81) | < 0.001 |
TC (mmol.l-1) | 5.07 (0.96) | 5.39 (1.03) | 5.76 (1.07) | 5.97 (1.15) | 6.30 (1.35) | < 0.001 |
HDL-C (mmol.l-1) | 1.43 (0.27) | 1.28 (0.25) | 1.16 (0.21) | 1.06 (0.19) | 0.91 (0.18) | < 0.001 |
TGs (mmol.l-1) | 0.86 (0.21) | 1.28 (0.28) | 1.70 (0.34) | 2.19 (0.44) | 3.59 (1.38) | < 0.001 |
Ln-TGs | -0.19 (0.26) | 0.23 (0.21) | 0.51 (0.20) | 0.76 (0.20) | 1.22 (0.32) | < 0.001 |
FPG (mmol.l-1) | 5.01 (1.17) | 5.26 (1.55) | 5.53 (2.00) | 5.91 (2.46) | 6.23 (2.59) | < 0.001 |
PCPG (mmol.l-1) | 5.79 (1.76) | 6.25 (2.16) | 6.94 (3.18) | 7.56 (3.35) | 8.35 (3.90) | < 0.001 |
Incident CVD | 9.7 (7.4-12.6) | 13.9 (10.9-17.7) | 12.3 (9.7-15.8) | 15.3 (11.9-19.7) | 15.2 (11.8-19.7) | 0.076 |